$ADAP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Adaptimmune Therapeutics PLC. Get notifications about new insider transactions in Adaptimmune Therapeutics PLC for free.

Page: < prev 1 2

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 01 2018	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Sell	S	13.49	50,000	674,500	4,920,010	5 M to 4.9 M (-1.01 %)
Jun 01 2018	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Sell	S	13.52	121,000	1,635,920	4,970,010	5.1 M to 5 M (-2.38 %)
May 16 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	13.50	10,300	139,050	5,091,010	5.1 M to 5.1 M (-0.20 %)
May 16 2018	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Sell	S	13.50	10,300	139,050	5,091,010	5.1 M to 5.1 M (-0.20 %)
Mar 29 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	11.53	31,983	368,764	5,101,310	5.1 M to 5.1 M (-0.62 %)
Mar 29 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	11.50	1,016,084	11,684,966	5,133,293	6.1 M to 5.1 M (-16.52 %)
Mar 29 2018	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Sell	S	11.53	31,983	368,764	5,101,310	5.1 M to 5.1 M (-0.62 %)
Mar 29 2018	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Sell	S	11.50	1,016,084	11,684,966	5,133,293	6.1 M to 5.1 M (-16.52 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	Viswanathan Ravi	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	Viswanathan Ravi	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	Sonsini Peter W.	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	Sonsini Peter W.	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	SANDELL SCOTT D	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	SANDELL SCOTT D	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	KERINS PATRICK J	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	KERINS PATRICK J	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	Florence Anthony A. Jr.	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	Florence Anthony A. Jr.	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	BASKETT FOREST	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	BASKETT FOREST	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	BARRIS PETER J	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	BARRIS PETER J	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	BARRETT M JAMES	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	BARRETT M JAMES	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	New Enterprise Associates 14, ...	10% Owner	Buy	P	1.92	6,000,000	11,500,200	79,978,672	74 M to 80 M (+8.11 %)
Mar 28 2018	ADAP	Adaptimmune Therap ...	New Enterprise Associates 14, ...	10% Owner	Buy	P	1.90	571,164	1,087,553	73,978,672	73.4 M to 74 M (+0.78 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Viswanathan Ravi	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Viswanathan Ravi	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Viswanathan Ravi	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Sonsini Peter W.	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Sonsini Peter W.	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Sonsini Peter W.	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	SANDELL SCOTT D	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	SANDELL SCOTT D	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	SANDELL SCOTT D	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	KERINS PATRICK J	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	KERINS PATRICK J	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	KERINS PATRICK J	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Florence Anthony A. Jr.	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Florence Anthony A. Jr.	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	Florence Anthony A. Jr.	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BASKETT FOREST	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BASKETT FOREST	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BASKETT FOREST	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BARRIS PETER J	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BARRIS PETER J	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BARRIS PETER J	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BARRETT M JAMES	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BARRETT M JAMES	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	BARRETT M JAMES	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	New Enterprise Associates 14, ...	10% Owner	Buy	P	1.95	294,090	572,358	73,407,508	73.1 M to 73.4 M (+0.40 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	New Enterprise Associates 14, ...	10% Owner	Buy	P	1.90	869,574	1,655,669	73,113,418	72.2 M to 73.1 M (+1.20 %)
Mar 23 2018	ADAP	Adaptimmune Therap ...	New Enterprise Associates 14, ...	10% Owner	Buy	P	1.81	104,844	189,820	72,243,844	72.1 M to 72.2 M (+0.15 %)
Mar 22 2018	ADAP	Adaptimmune Therap ...	Rawcliffe Adrian	Chief Financial Off ...	Sell	S	1.71	600,000	1,026,000	0	600 K to 0 (-100.00 %)
Jan 17 2018	ADAP	Adaptimmune Therap ...	TAYTON-MARTIN HELEN KATRINA	Chief Business Offi ...	Option Exercise	A	0.00	153,648	215	153,648
Jan 17 2018	ADAP	Adaptimmune Therap ...	TAYTON-MARTIN HELEN KATRINA	Chief Business Offi ...	Option Exercise	A	1.30	687,984	894,379	687,984
Jan 17 2018	ADAP	Adaptimmune Therap ...	Rawcliffe Adrian	Chief Financial Off ...	Option Exercise	A	0.00	153,648	215	153,648
Jan 17 2018	ADAP	Adaptimmune Therap ...	Rawcliffe Adrian	Chief Financial Off ...	Option Exercise	A	1.30	687,984	894,379	687,984
Jan 17 2018	ADAP	Adaptimmune Therap ...	Binder-Scholl Gwendolyn Knowlt ...	Chief Technology Of ...	Option Exercise	A	0.00	96,036	134	96,036
Jan 17 2018	ADAP	Adaptimmune Therap ...	Binder-Scholl Gwendolyn Knowlt ...	Chief Technology Of ...	Option Exercise	A	1.30	429,984	558,979	429,984
Jan 17 2018	ADAP	Adaptimmune Therap ...	Bertrand William C JR	Chief Operating Off ...	Option Exercise	A	0.00	144,048	202	144,048
Jan 17 2018	ADAP	Adaptimmune Therap ...	Bertrand William C JR	Chief Operating Off ...	Option Exercise	A	1.30	644,976	838,469	644,976
Jan 17 2018	ADAP	Adaptimmune Therap ...	Amado Rafael	Chief Medical Offic ...	Option Exercise	A	0.00	192,060	269	192,060
Jan 17 2018	ADAP	Adaptimmune Therap ...	Amado Rafael	Chief Medical Offic ...	Option Exercise	A	1.30	859,968	1,117,958	859,968
Jan 17 2018	ADAP	Adaptimmune Therap ...	Noble James	Chief Executive Off ...	Option Exercise	A	0.00	384,120	538	384,120
Jan 17 2018	ADAP	Adaptimmune Therap ...	Noble James	Chief Executive Off ...	Option Exercise	A	1.30	1,719,936	2,235,917	1,719,936
Jul 03 2017	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Option Exercise	A	0.75	302,561	226,921	302,561
Jul 03 2017	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Option Exercise	A	0.75	220,788	165,591	220,788
Jul 03 2017	ADAP	Adaptimmune Therap ...	Duncan Barbara Gayle	Director	Option Exercise	A	0.75	228,765	171,574	228,765
Jul 03 2017	ADAP	Adaptimmune Therap ...	Zaks Tal Zvi	Director	Option Exercise	A	0.75	144,000	108,000	144,000
Jul 03 2017	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Option Exercise	A	0.75	223,779	167,834	223,779
Jul 03 2017	ADAP	Adaptimmune Therap ...	Sigal Charles Elliott	Director	Option Exercise	A	0.75	220,788	165,591	220,788
Jul 03 2017	ADAP	Adaptimmune Therap ...	Kerr Giles Francis Bertram	Director	Option Exercise	A	0.75	144,000	108,000	144,000
Jul 03 2017	ADAP	Adaptimmune Therap ...	Alleva Lawrence M	Director	Option Exercise	A	0.75	243,724	182,793	243,724
Mar 28 2017	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	4.20	1,190,476	4,999,999	6,149,377	5 M to 6.1 M (+24.01 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Buy	P	4.20	1,190,476	4,999,999	6,149,377	5 M to 6.1 M (+24.01 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	Viswanathan Ravi	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	Sonsini Peter W.	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	SANDELL SCOTT D	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	KERINS PATRICK J	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	Florence Anthony A. Jr.	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	BASKETT FOREST	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	BARRIS PETER J	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	BARRETT M JAMES	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Mar 28 2017	ADAP	Adaptimmune Therap ...	New Enterprise Associates 14, ...	10% Owner	Buy	P	0.70	12,870,000	9,009,000	72,139,000	59.3 M to 72.1 M (+21.71 %)
Jan 18 2017	ADAP	Adaptimmune Therap ...	Binder-Scholl Gwendolyn Knowlt ...	Chief Technology Of ...	Option Exercise	A	0.72	2,072,976	1,492,543	2,072,976
Jan 18 2017	ADAP	Adaptimmune Therap ...	Rawcliffe Adrian	Chief Financial Off ...	Option Exercise	A	0.72	2,072,976	1,492,543	2,072,976
Jan 18 2017	ADAP	Adaptimmune Therap ...	Amado Rafael	Chief Medical Offic ...	Option Exercise	A	0.72	2,072,976	1,492,543	2,072,976
Jan 18 2017	ADAP	Adaptimmune Therap ...	TAYTON-MARTIN HELEN KATRINA	Chief Operating Off ...	Option Exercise	A	0.72	2,072,976	1,492,543	2,072,976
Jan 18 2017	ADAP	Adaptimmune Therap ...	Noble James	Chief Executive Off ...	Option Exercise	A	0.72	2,072,976	1,492,543	2,072,976
Dec 01 2016	ADAP	Adaptimmune Therap ...	Kerr Giles Francis Bertram	Director	Option Exercise	A	0.81	288,000	233,280	288,000
Dec 01 2016	ADAP	Adaptimmune Therap ...	Zaks Tal Zvi	Director	Option Exercise	A	0.81	288,000	233,280	288,000
Aug 12 2016	ADAP	Adaptimmune Therap ...	Knowles Jonathan Kenneth Charl ...	Director	Option Exercise	A	1.27	217,222	275,872	217,222
Aug 12 2016	ADAP	Adaptimmune Therap ...	Alleva Lawrence M	Director	Option Exercise	A	1.27	196,678	249,781	196,678
Aug 12 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Option Exercise	A	1.27	186,142	236,400	186,142
Aug 12 2016	ADAP	Adaptimmune Therap ...	MOTT DAVID M	Director	Option Exercise	A	1.27	191,410	243,091	191,410
Aug 12 2016	ADAP	Adaptimmune Therap ...	Behbahani Ali	Director	Option Exercise	A	1.27	184,562	234,394	184,562
Aug 12 2016	ADAP	Adaptimmune Therap ...	Sigal Charles Elliott	Director	Option Exercise	A	1.27	184,562	234,394	184,562
Aug 12 2016	ADAP	Adaptimmune Therap ...	Laing Ian Michael	Director	Option Exercise	A	1.27	144,000	182,880	144,000
May 25 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	10.48	518,400	5,432,832	29,753,404	29.2 M to 29.8 M (+1.77 %)
May 25 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	10.40	1,191,600	12,392,640	29,235,004	28 M to 29.2 M (+4.25 %)
May 25 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	10.04	2,400	24,096	28,043,404	28 M to 28 M (+0.01 %)
May 25 2016	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Buy	P	10.48	518,400	5,432,832	29,753,404	29.2 M to 29.8 M (+1.77 %)
May 25 2016	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Buy	P	10.40	1,191,600	12,392,640	29,235,004	28 M to 29.2 M (+4.25 %)
May 25 2016	ADAP	Adaptimmune Therap ...	ORBIMED ADVISORS LLC	Director	Buy	P	10.04	2,400	24,096	28,043,404	28 M to 28 M (+0.01 %)
May 19 2016	ADAP	Adaptimmune Therap ...	Sigal Charles Elliott	Director	Buy	P	1.56	15,000	23,400	314,100	299.1 K to 314.1 K (+5.02 %)
May 18 2016	ADAP	Adaptimmune Therap ...	Sigal Charles Elliott	Director	Buy	P	1.55	15,000	23,250	299,100	284.1 K to 299.1 K (+5.28 %)
May 18 2016	ADAP	Adaptimmune Therap ...	Sigal Charles Elliott	Director	Buy	P	1.53	15,000	22,950	284,100	269.1 K to 284.1 K (+5.57 %)
May 18 2016	ADAP	Adaptimmune Therap ...	Sigal Charles Elliott	Director	Buy	P	1.50	15,000	22,500	269,100	254.1 K to 269.1 K (+5.90 %)
Jan 20 2016	ADAP	Adaptimmune Therap ...	Rawcliffe Adrian	Chief Financial Off ...	Option Exercise	A	1.27	939,948	1,195,332	939,948
Jan 20 2016	ADAP	Adaptimmune Therap ...	Binder-Scholl Gwendolyn Knowlt ...	EVP, Adaptimmune LL ...	Option Exercise	A	1.27	704,961	896,499	704,961
Jan 20 2016	ADAP	Adaptimmune Therap ...	TAYTON-MARTIN HELEN KATRINA	Chief Operating Off ...	Option Exercise	A	1.27	939,948	1,195,332	939,948
Jan 20 2016	ADAP	Adaptimmune Therap ...	Noble James	Chief Executive Off ...	Option Exercise	A	1.27	1,968,016	2,502,726	1,968,016
Jan 20 2016	ADAP	Adaptimmune Therap ...	Amado Rafael	Chief Medical Offic ...	Option Exercise	A	1.27	939,948	1,195,332	939,948

Page: < prev 1 2